Your session is about to expire
← Back to Search
CBD for Endometriosis Pain
Study Summary
This trial will study whether CBD can help relieve pain and improve quality of life for people with endometriosis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a woman with liver disease or my liver tests have been high in the past year.I am a woman aged between 18 and 45.I have had a stroke or heart attack.I have not had suicidal thoughts or uncontrolled depression in the last year.I have or might have breast cancer based on a physical exam.I am a woman currently using Clobazam or Valproate and cannot stop for the study.I agree to switch to NETA for endometriosis treatment during the study.I am a woman who uses opioids daily for a chronic pain condition other than endometriosis.I have used cannabis products within the last 30 days.My BMI is over 35.I am currently using a contraceptive implant that contains progestin.I am not pregnant, breastfeeding, or trying to conceive.I regularly take medication that makes me sleepy and cannot stop for the study.I am not planning to have surgery for endometriosis during the study.I drink more than 3 alcoholic beverages daily on average.I have had or currently have deep vein thrombosis or a lung clot.I use LARCs for birth control or endometriosis and agree to switch to Norethindrone for the study.I have been diagnosed with endometriosis through surgery, and I experience significant pain from it.I have more than 3 risk factors for heart disease, like high blood pressure, diabetes, high cholesterol, obesity, or smoking.
- Group 1: Group B - Low Dose CBD
- Group 2: Group C - High Dose CBD
- Group 3: Group A - Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you elaborate on the risks associated with high doses of CBD?
"There is some efficacy data and multiple rounds of safety data available for Group C - High Dose CBD, so it received a score of 3."
Are there previous examples of Group C - High Dose CBD's effectiveness?
"Currently, there are a total of 92 active clinical trials for Group C - High Dose CBD. Of these, 23 are in Phase 3. This treatment is being studied most extensively in Ribeirao Preto and Sao Paulo, Brazil; however, there are 931 research sites worldwide runningGroup C - High Dose CBD trials."
Who meets the requirements to be a part of this experiment?
"This study is looking for 36 individuals aged 18 to 45 who suffer from pelvic pain caused by endometriosis. Eligible candidates must meet the following requirements: Be female, not be scheduled for any surgery related to endometriosis during the study, agree to use contraception if they are not sterile, be willing to switch their current medication to Norethindrone acetate (NETA) if necessary, have a surgical diagnosis of endometriosis that has been confirmed by visualization and/or histopathology with accompanying moderate to severe pain (>3 on VAS)."
Are recruitment efforts for this trial ongoing?
"This study is not recruiting at this moment. It was initially posted on December 4th, 2020 and updated December 8th, 2021. For individuals looking for other studies, there are 136 clinical trials actively recruiting patients with pelvic pain and 92 trials for Group C - High Dose CBD searching for participants."
Is this clinical trial open to patients who are legal adults?
"The age requirements for participants in this clinical trial are that individuals must be over 18 but under 45."
How many people have been recruited for this clinical trial thus far?
"Unfortunately, this particular study is no longer taking patients. The trial was initially posted on December 4th 2020 and the listing was last updated on December 8th 2021. For other options, please note that there are 136 trials recruiting for pelvic pain and 92 studies looking for Group C - High Dose CBD participants."
What are the main health concerns that Group C - High Dose CBD addresses?
"Group C - High Dose CBD is commonly used to treat contraception but it can also be prescribed for other conditions like female castration, oral contraceptives, and the vasomotor system."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger